The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
Work
Year: 2019
Type: article
Source: Nature
Institutions Amgen (United States), City of Hope, Indiana University – Purdue University Indianapolis, Indiana University School of Medicine, Queen Elizabeth Hospital +4 more
Cites: 34
Cited by: 1,792
Related to: 10
FWCI: 182.7
Citation percentile (by year/subfield): 100
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: closed